Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) Shares Shorted: Short Interest Up 298.3% in September

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totaling 705 shares, a growth of 298.3% from the September 15th total of 177 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily volume of 6,785 shares, the short-interest ratio is presently 0.1 days.

Santen Pharmaceutical Stock Up 0.4%

OTCMKTS SNPHY traded up $0.04 on Friday, hitting $10.70. 10,196 shares of the company’s stock were exchanged, compared to its average volume of 2,715. Santen Pharmaceutical has a 52 week low of $9.22 and a 52 week high of $13.93. The stock has a 50-day moving average of $11.46 and a 200-day moving average of $11.73.

About Santen Pharmaceutical

Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and markets prescription ophthalmic medicines and related products used to treat eye diseases and disorders.

Its product portfolio addresses conditions including glaucoma, dry eye disease, retinal diseases, ocular allergies, infections and inflammation. Santen also develops treatments for other serious vision-related conditions and provides products for eye-care professionals and patients.

Founded in 1890 and headquartered in Osaka, Japan, Santen has built a business serving patients and healthcare providers in Japan and international markets, including other parts of Asia, Europe and North America.